Silverfin false false 31/03/2024 31/03/2024 01/04/2023 During the year the principal activity was that of medical services. W Mukonoweshuro 26/10/2015 R Mukonoweshuro 26/10/2015 09842502 2024-03-31 09842502 bus:Director1 2024-03-31 09842502 bus:Director2 2024-03-31 09842502 2023-03-31 09842502 core:CurrentFinancialInstruments 2024-03-31 09842502 core:CurrentFinancialInstruments 2023-03-31 09842502 2023-04-01 2024-03-31 09842502 bus:Micro-entities 2023-04-01 2024-03-31 09842502 bus:FilletedAccounts 2023-04-01 2024-03-31 09842502 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 09842502 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09842502 bus:Director1 2023-04-01 2024-03-31 09842502 bus:Director2 2023-04-01 2024-03-31 09842502 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Company No: 09842502 (England and Wales)

NEUROIMAGING SW LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2024
Pages for filing with the registrar

NEUROIMAGING SW LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 March 2024

Contents

NEUROIMAGING SW LIMITED

BALANCE SHEET

As at 31 March 2024
NEUROIMAGING SW LIMITED

BALANCE SHEET (continued)

For the financial year ended 31 March 2024
2024 2023
£ £
Fixed assets 1,914 3,417
Current assets 60,334 97,372
Prepayments and accrued income 2,391 3,120
Creditors: amounts falling due within one year ( 24,093) ( 47,149)
Net current assets 38,632 53,343
Total assets less current liabilities 40,546 56,760
Accruals and deferred income ( 2,989) ( 2,899)
Net assets 37,557 53,861
Capital and reserves 37,557 53,861

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Neuroimaging SW Limited (registered number: 09842502) were approved and authorised for issue by the Board of Directors on 19 October 2024 and were signed on its behalf by:

W Mukonoweshuro
Director
NEUROIMAGING SW LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
NEUROIMAGING SW LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 March 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 09842502). The address of its registered office is Melville Building East, Unit 18, 23 Royal William Yard, Plymouth, PL1 3GW, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors - -

3. Directors’ benefits: advances, credit and guarantees

Advances

During the year, the Company advanced £40,164 to the directors (2023 - £72,274), of which £70,805 was repaid (2023 - £34,988). Interest was charged on this amount at the official HMRC rate and the loan is repayable on demand. The balance owed to the company at 31 March 2024 is £40,507 (2023 - £71,148).